Cargando…

P1077: HODGKIN LYMPHOMA IN PATIENTS WITH HIV: NATIONAL RETROSPECTIVE MULTICENTER STUDY

Detalles Bibliográficos
Autores principales:	Chekalov, A., Popova, M., Tsygankov, I., Rogacheva, Y., Volkov, N., Beynarovich, A., Lepik, K., Demchenkova, M., Schneider, T., Kopeikina, Y., Potapenko, V., Zyuzgin, I., Kolesnikova, M., Pospelova, T., Zinina, E., Myasnikov, A., Kaplanov, K., Ksenzova, T., Pavlyuchenko, E., Mikhaylova, N., Baykov, V., Kulagin, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429161/ http://dx.doi.org/10.1097/01.HS9.0000847176.96022.91

Ejemplares similares

P085: Epidemiology and results of the first line therapy of HIV-related Hodgkin Lymphoma: Russian retrospective multicenter study
por: Chekalov, Andrey, et al.
Publicado: (2022)

P1080: COMPARISON OF NIVOLUMAB 40 MG EFFICACY VERSUS 3 MG/KG IN PATIENTS WITH RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA
por: Fedorova, L., et al.
Publicado: (2022)

Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma
por: Fedorova, Liudmila V., et al.
Publicado: (2021)

Immunosuppressive Microenvironment and Efficacy of PD-1 Inhibitors in Relapsed/Refractory Classic Hodgkin Lymphoma: Checkpoint Molecules Landscape and Macrophage Populations
por: Gusak, Artem, et al.
Publicado: (2021)

A Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma
por: Lepik, Kirill V., et al.
Publicado: (2020)

Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition
por: Schmidt, Julie A., et al.
Publicado: (2017)

PB2308: NIVOLUMAB-BASED THERAPY OF RELAPSED OR REFRACTORY PRIMARY LARGE B-CELL LYMPHOMA OF IMMUNE-PRIVILEGED SITES AND DLBCL WITH SECONDARY CNS INVOLVEMENT
por: Gavrilenko, Andrey, et al.
Publicado: (2023)

PB2423: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH PRIOR INFECTION CAUSED BY THE SARS-COV-2 (COVID-19)
por: Siniaev, Aleksandr, et al.
Publicado: (2023)

1077. Heart Transplantation as Salvage Treatment for Intractable Infective Endocarditis
por: Tattevin, Pierre, et al.
Publicado: (2018)

P062: The efficacy and safety of nivolumab 40 mg therapy versus 3 mg/kg in patients with relapsed and refractory classic Hodgkin lymphoma
por: Fedorova, Liudmila, et al.
Publicado: (2022)

P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment
por: Fedorova, Liudmila, et al.
Publicado: (2022)

Drug responsiveness of leukemic cells detected in vitro at diagnosis correlates with therapy response and survival in patients with acute myeloid leukemia
por: Kolesnikova, Maria A., et al.
Publicado: (2021)

Effective Prognostic Model for Therapy Response Prediction in Acute Myeloid Leukemia Patients
por: Kolesnikova, Maria A., et al.
Publicado: (2023)

1077. Reduce Anti-Microbial Use in Extracorporeal Membrane Oxygenation: Reduce AMMO Study
por: Shah, Aditya, et al.
Publicado: (2019)

Real-to-imaginary ratio of the $\overline{p}p$ forward elastic scattering amplitude at 550, 757, and 1077 MeV/c
por: Schiavon, R P, et al.
Publicado: (1989)

Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2013)

Primary mucosal melanoma of the sinonasal tract: Report of 18 patients and analysis of 1077 patients in the literature
por: Khademi, Bijan, et al.
Publicado: (2015)

1077. Infectious complications after second allogeneic hematopoietic cell transplant (allo-HCT) in adult patients with hematological malignancies
por: Maurer, Stephen, et al.
Publicado: (2020)

Intravitreal Administration of HA-1077, a ROCK Inhibitor, Improves Retinal Function in a Mouse Model of Huntington Disease
por: Li, Mei, et al.
Publicado: (2013)

P1179: PROGNOSIS OF PATIENTS WITH AGGRESSIVE REFRACTORY B-NHL TREATED WITH GLOFITAMAB IN REAL CLINICAL PRACTICE
por: Fedorova, Liudmila, et al.
Publicado: (2023)

The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells
por: Abe, Hideyuki, et al.
Publicado: (2014)

1077. Understanding the Psychosocial Burden Associated with Hospitalization Among Adults Diagnosed with COVID-19 in the United States
por: Ansari, Wajeeha, et al.
Publicado: (2022)

Computational and Rational Design of Single-Chain Antibody against Tick-Borne Encephalitis Virus for Modifying Its Specificity
por: Baykov, Ivan K., et al.
Publicado: (2021)

P1207: MULTICENTER RANDOMIZED CONTROLLED (COMPARATIVE) OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF THE R-DA-EPOCH-21 AND R-MNHL-BFM-90 ± AUTO- HSCT PROGRAMS IN PATIENTS WITH DE NOVO DIFFUSE B-CELL LAR
por: Magomedova, A., et al.
Publicado: (2022)

Investigation of the inhibitory effects of HA-1077 and Y-32885 on the translocation of PKCbetaI, PKCbetaII and PKCzeta in human neutrophils.
por: Siomboing, X, et al.
Publicado: (2001)

Assessment of the application for renewal of authorisation of Levucell SC (Saccharomyces cerevisiae CNCM I‐1077) as a feed additive for lambs and horses
por: Bampidis, Vasileios, et al.
Publicado: (2019)

Bifidobacterium longum CCFM1077 Ameliorated Neurotransmitter Disorder and Neuroinflammation Closely Linked to Regulation in the Kynurenine Pathway of Autistic-like Rats
por: Kong, Qingmin, et al.
Publicado: (2022)

P1384: EFFECT OF NUTRITIONAL SUPPORT ON THE INCIDENCE OF MUCOSITIS IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN PATIENTS WITH HODGKIN’S LYMPHOMA. (INTERIM RESULTS)
por: Volchenkov, S., et al.
Publicado: (2022)

PMS1077 Sensitizes TNF-α Induced Apoptosis in Human Prostate Cancer Cells by Blocking NF-κB Signaling Pathway
por: Shi, Jie, et al.
Publicado: (2013)

Clinical and Prognostic Significance of Cell Sensitivity to Chemotherapy Detected In Vitro on Treatment Response and Survival of Leukemia Patients
por: Kolesnikova, Maria, et al.
Publicado: (2019)

MicroRNAs in the Myelodysplastic Syndrome
por: Veryaskina, Y. A., et al.
Publicado: (2021)

1077 Adverse events following measles, mumps, and rubella (MMR) vaccine in adults reported to the Vaccine Adverse Event Reporting System, 2003-2013
por: Sukumaran, Lakshmi, et al.
Publicado: (2014)

Assessment of the application for renewal of authorisation of Levucell(®) SC (Saccharomyces cerevisiae CNCM I‐1077) as a feed additive for dairy ewes and dairy goats
por: Bampidis, Vasileios, et al.
Publicado: (2018)

P1077: RISK OF IMPAIRED OVARIAN RESERVE AND ADVERSE PREGNANCY OUTCOMES AFTER TREATMENT FOR CHILDHOOD HODGKIN LYMPHOMA; THE DCOG LATER-VEVO STUDY.
por: Drechsel, Katja, et al.
Publicado: (2023)

Variation in the basic characteristics of inclastic nucleon and nuclear collision in the energy range 10 (In Russian)
por: Erlykin, A D, et al.
Publicado: (1971)

A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure
por: Lepik, Kirill V., et al.
Publicado: (2020)

Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab
por: Kulagin, Alexander D., et al.
Publicado: (2021)

Cloning and Expression of Synthetic Genes Encoding the Broad Antimicrobial Spectrum Bacteriocins SRCAM 602, OR-7, E-760, and L-1077, by Recombinant Pichia pastoris
por: Arbulu, Sara, et al.
Publicado: (2015)

HA1077 displays synergistic activity with daclatasvir against hepatitis C virus and suppresses the emergence of NS5A resistance-associated substitutions in mice
por: Lee, Seung-Hoon, et al.
Publicado: (2018)

TULA Proteins in Men, Mice, Hens, and Lice: Welcome to the Family
por: Tsygankov, Alexander Y.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uncchtvvestmo30onoa0dhhi1f